bevacizumab in nonsquamous lung cancer
Published 7 years ago • 262 plays • Length 7:40Download video MP4
Download video MP3
Similar videos
-
4:02
bevacizumab in nonsquamous nsclc
-
5:08
ultimate study: paclitaxel bevacizumab in non-squamous nsclc
-
4:46
bevacizumab in lung cancer
-
5:39
use of bevacizumab for lung cancer
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
3:46
what is the role of bevacizumab in stage iv nsclc?
-
1:09
dr. herbst on the bevacizumab biosimilar in lung cancer
-
3:46
patient selection for frontline bevacizumab in nsclc
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
3:29
bevacizumab in egfr-mutant nsclc
-
8:04
refining use of egfr tkis, adding bevacizumab
-
1:14
clinical trials exploring bevacizumab in nsclc
-
5:36
maintenance therapy for advanced nonsquamous nsclc
-
5:15
metastatic nsclc: a look at the impower150 trial
-
5:02
addition of bevacizumab to up-front therapy for egfr nsclc
-
3:22
use of bevacizumab in stage iv nsclc with no actionable mutations
-
1:28
avastin not as beneficial to older lung cancer patients | dana-farber cancer institute
-
8:52
immunotherapy chemotherapy in nonsquamous nsclc
-
3:25
use of ramucirumab for patients with squamous or nonsquamous lung cancer